blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3407868

EP3407868 - LIQUID FORMULATION OF A VEGF ANTAGONIST [Right-click to bookmark this link]
StatusExamination is in progress
Status updated on  17.04.2020
Database last updated on 08.10.2024
FormerRequest for examination was made
Status updated on  02.11.2018
FormerThe international publication has been made
Status updated on  04.08.2017
Formerunknown
Status updated on  03.02.2017
Most recent event   Tooltip29.01.2024New entry: Renewal fee paid 
Applicant(s)For all designated states
Formycon AG
Fraunhoferstrasse 15
82152 Martinsried/Planegg / DE
[2018/49]
Inventor(s)01 / SIGL, Rainer
Fichtenstrasse 15a
86899 Landsberg am Lech / DE
 [2018/49]
Representative(s)Maiwald GmbH
Elisenhof
Elisenstraße 3
80335 München / DE
[N/P]
Former [2018/49]Maiwald Patent- und Rechtsanwaltsgesellschaft mbH
Elisenhof
Elisenstraße 3
80335 München / DE
Application number, filing date17701350.526.01.2017
[2018/49]
WO2017EP51662
Priority number, dateEP2016015276726.01.2016         Original published format: EP 16152767
EP2016019949718.11.2016         Original published format: EP 16199497
[2018/49]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017129685
Date:03.08.2017
Language:EN
[2017/31]
Type: A1 Application with search report 
No.:EP3407868
Date:05.12.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 03.08.2017 takes the place of the publication of the European patent application.
[2018/49]
Search report(s)International search report - published on:EP03.08.2017
ClassificationIPC:A61K9/00, A61K38/18
[2018/49]
CPC:
A61K38/179 (EP,US); A61K47/02 (EP,US); A61K47/10 (EP,US);
A61K47/22 (US); A61K47/26 (EP,US); A61K9/0019 (EP,US);
A61K9/0048 (EP,US); A61K9/0051 (EP,US); A61P27/10 (EP,US);
C07K16/22 (US); A61K9/08 (US); C07K14/71 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/49]
TitleGerman:FLÜSSIGFORMULIERUNG EINES VEGF-ANTAGONISTEN[2018/49]
English:LIQUID FORMULATION OF A VEGF ANTAGONIST[2018/49]
French:FORMULATION LIQUIDE D'UN ANTAGONISTE DU VEGF[2018/49]
Entry into regional phase21.08.2018National basic fee paid 
21.08.2018Designation fee(s) paid 
21.08.2018Examination fee paid 
Examination procedure21.08.2018Examination requested  [2018/49]
21.08.2018Date on which the examining division has become responsible
22.03.2019Amendment by applicant (claims and/or description)
21.04.2020Despatch of a communication from the examining division (Time limit: M06)
29.10.2020Reply to a communication from the examining division
26.08.2022Despatch of a communication from the examining division (Time limit: M04)
22.12.2022Reply to a communication from the examining division
Fees paidRenewal fee
29.01.2019Renewal fee patent year 03
28.01.2020Renewal fee patent year 04
29.01.2021Renewal fee patent year 05
28.01.2022Renewal fee patent year 06
30.01.2023Renewal fee patent year 07
29.01.2024Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[ID]WO2007149334  (REGENERON PHARMA [US], et al);
 [XI]US2015157709  (EVERETT RICHARD [US], et al);
 [XI]US2015182623  (EVERETT RICHARD [US], et al)
by applicantIB75319
 WO9410202
 WO9630046
 US5731144
 US5731424
 WO9845331
 WO9845332
 US6124449
 US6207816
 EP0666868
 US6582959
 US2003190317
 US6703020
 WO2005044853
 WO2006104852
 WO2007149334
 WO2009155724
 WO2010060748
 WO2011135067
 WO2015071348
 US2015157709
 US2015182623
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.